Orbimed Advisors LLC Cti Biopharma Corp Transaction History

Orbimed Advisors LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 14, 2022	SELL	$1.44 - $2.86 $10.8 Million - $21.5 Million	-7,520,600 Closed	0 $0
Q1 2021 May 17, 2021	SELL	$2.68 - $3.8 $5.36 Million - $7.6 Million	-2,000,000 Reduced 21.01%	7,520,600 $21.9 Million
Q1 2020 May 15, 2020	BUY	$0.69 - $1.54 $3.12 Million - $6.96 Million	4,520,600 Added 90.41%	9,520,600 $8.76 Million
Q3 2017 Nov 14, 2017	BUY	$3.12 - $3.65 $15.6 Million - $18.3 Million	5,000,000	5,000,000 $16 Million

Ticker CTIC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 114,385,000
Market Cap $1.04B
Description
CTI BioPharma Corp., a biopharmaceutical company, focuses on the acquisition, development, and commercialization of novel targeted therapies for blood-related cancers in the United States. It offers VONJO (pacritinib), an investigational oral kinase inhibitor with specificity for JAK2, FLT3, IRAK1, and CSF1R for the treatment of adult patients w...

Get notified when there are updates to the investment portfolio of Orbimed Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Orbimed Advisors LLC with notifications on news.